| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CRMD sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 774.7K | - | - | |
| COO | 270.5K | $2.24M | - | |
| Other | 260.7K | $2.16M | - | |
| Dir | 231.5K | - | - | |
| Other | 133.2K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 14, 2015 | Pfaffle Antony | Interim Chief Medical Officer | Sell | 16,725 | $6.49 | $108,543.44 | -100% | |
| Apr 15, 2015 | Milby Randy | Chief Executive Officer | Buy | 730 | $8.55 | $6,241.50 | +1.4% | |
| Feb 27, 2015 | Milby Randy | Chief Executive Officer | Buy | 1,211 | $5.16 | $6,248.76 | +2.4% | |
| Feb 13, 2015 | Milby Randy | Chief Executive Officer | Buy | 1,911 | $3.27 | $6,248.97 | +4.0% |